Abstract Details
|
Lakshmi S. Amaravadi, PhD
(Sr. Director, Translational Medicine)
PRESENTER |
No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| Katherine A. Riester, MPH (Biogen) | No disclosure on file |
| Marianne T. Sweetser, MD, PhD (Alnylam Pharmaceuticals) | Dr. Sweetser has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Dr. Sweetser has received stock or an ownership interest from Alnylam Pharmaceuticals. |
| Jacob S. Elkins, MD | No disclosure on file |
| Jack P. Antel, MD, FAAN (Montreal Neurologic Hospital) | Dr. Antel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi, roche, biogen, wave,nervgen. The institution of Dr. Antel has received research support from Novartis canada bristol myers squib. Dr. Antel has a non-compensated relationship as a past president with ACTRIMS that is relevant to AAN interests or activities. |